Dr. Lilia Uralsky, MD, MS

Dr. Uralsky practices at Butler Memorial Hospital in Butler, Pennsylvania, part of West Virginia University Health System.

Dr. Uralsky's NPI, 1700240058, was assigned on April 12, 2016. Dr. Uralsky holds Pennsylvania license MD467925.

Dr. Uralsky's primary practice is Butler Memorial Hospital, at One Hospital Way, Butler, PA 16001 in Butler County. The practice phone is (724) 284-4403. Dr. Uralsky also practices at Butler Memorial Hospital, 1 Hospital Way, Butler, PA 16001.

Dr. Uralsky's primary practice is Butler Memorial Hospital in Butler, Pennsylvania, part of West Virginia University Health System. Dr. Uralsky is also affiliated with Allegheny General Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uralsky practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Uralsky's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Uralsky is licensed in Pennsylvania.

CMS data shows 187 Medicare services from Dr. Uralsky across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $14,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Uralsky in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uralsky's median patient age at 72, with 36% women.

In 2024, Dr. Uralsky wrote 101 Medicare Part D claims for 45 patients. 89% of them were for generic drugs. CMS names the drug for 54 of them, across 3 drugs with 11 or more claims each, at $364 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Uralsky for performance year 2024, reported through an alternative payment model (APM). Dr. Uralsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 48 general payments to Dr. Uralsky from 16 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 57% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,664.